Evidence map›Paper›PMID 41540995›Full record

ReviewFarmaceuticos comunitarios2026

Phytotherapy in Community Pharmacy: Legal Aspects, Uses, and Interactions.

I Busto Domínguez, J López Gil, M D Parra Astorgano, R Prats Mas, M Roig Marin-Yaseli, I Villegas Lama

Abstract readReview
In one paragraph

Review in Farmaceuticos comunitarios, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

I Busto DomínguezMember of the SEFAC Phytotherapy Commission. Pharmacist. Pontevedra España.
J López GilMember of the SEFAC Phytotherapy Commission. Community pharmacist in Águilas (Murcia) España.
M D Parra AstorganoMember of the SEFAC Phytotherapy Commission. Community pharmacist in Valladolid España.
R Prats MasCoordinator of the SEFAC Phytotherapy Commission. Community pharmacist in Denia (Alicante) España.
M Roig Marin-YaseliMember of the SEFAC Phytotherapy Commission. Community pharmacist in Zaragoza España.
I Villegas LamaMember of the SEFAC Phytotherapy Commission. Department of Pharmacology, Faculty of Pharmacy, University of Seville España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phytotherapy, an ancient practice based on the use of plant-based products, has recently seen a strong resurgence, driven by a growing preference for "natural" products. In the context of community pharmacy, it is presented as an alternative or complement to conventional treatments, especially for mild or chronic conditions, or as an adjuvant for serious illnesses. However, its use is not without risks, due to the variability in the composition of marketed products, the pharmacological action of their active ingredients, and the lack of uniform regulatory framework. There are different legal categories for these products, depending on their composition, indication, and scientific backing. Some, such as dietary supplements and medical devices, are available without medical supervision despite containing active ingredients used in prescription medications. In this context, the community pharmacist plays an essential role in patient counseling and promoting the rational and safe use of phytopharmaceuticals. In Spain, 192 authorized plant-based active ingredients are currently identified, underscoring the importance of their proper management in healthcare practice. Although generally well tolerated, these products are not free from adverse effects, especially in vulnerable populations such as pregnant women, children, the elderly, immunosuppressed individuals, and patients on multiple medications. Furthermore, they can generate significant interactions. Therefore, their dispensing and recommendation require specialized and up-to-date knowledge on the part of the pharmacist, thus ensuring a safe and effective therapeutic approach.

Indexed as

Community Pharmacy ServicesPharmaciesPhytotherapyDietary SupplementsHumansPharmacistsSpainCommunity PharmacistsCommunity Pharmacy ServicesMedicinalPharmacy LegislationPhytotherapyPlants

Identifiers

PMID41540995
PMCPMC12801703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.